US Patent Issued to UCB Biopharma on June 17 for "Antibody molecules which bind CD22" (British Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,117, issued on June 17, was assigned to UCB Biopharma SRL (Brussels).

"Antibody molecules which bind CD22" was invented by Helene Margaret Finney (Slough, Great Britain), Stephen Edward Rapecki (Slough, Great Britain), Kerry Louise Tyson (Slough, Great Britain) and Michael John Wright (Slough, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibody molecules comprising a binding domain specific to CD22, said binding domain comprising SEQ ID NO: 1, 2, 3, 4, 5 and 6 or 7. The disclosure also extends to pharmaceutical compositions comprising said antibody molecules and use of the antibody molecules/compos...